Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8
1 clinical trials · Condition
◉ Watch Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study") (NCT07649304) | National Cancer Institute (NCI) | 2026-10-09 |
Track Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.